IOVA
Iovance Biotherapeutics Inc
14.60$
+9.8%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | +97.1% | +2.8% | +48.3% | +4,250.5% | +88.2% | +25.9% | -33.1% | +21.5% | +12.5% | +28.6% | -17.7% | +39.0% | – | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -81.6% | +1,180.9% | -26.7% | +8.6% | +4.5% | 0.0% | +9.7% | -0.2% | -64.0% | +111.7% | +0.6% | +66.3% | +332.0% | +27.0% | +14.4% | +9.2% | +13.9% | -97.5% | -7,239.7% | – | +4,328.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +50.3% | -101.5% | – | +1,908.7% | +183.6% | -62.4% | -23.0% | – | |
| – | +14.9% | +70.6% | +18.2% | -9.7% | +16.6% | -3.8% | +23.3% | +13.8% | -1.9% | +12.7% | +27.2% | +5.8% | +30.4% | +5.0% | -13.5% | -12.6% | +21.8% | +6.7% | +11.0% | +5.2% | +15.7% | -9.7% | +7.5% | -1.2% | +11.1% | +2.7% | +4.4% | +1.4% | -0.1% | -8.8% | -22.2% | +9.9% | +5.8% | +6.4% | +3.2% | -5.3% | -8.4% | -9.2% | +2.3% | – | |
| – | -51.6% | -16.2% | -7.8% | +16.9% | +17.1% | +29.6% | -2.0% | +4.2% | +5.8% | +20.7% | +19.7% | -7.7% | +8.4% | +27.5% | +3.6% | +10.9% | +1.0% | +22.0% | -1.6% | +8.2% | +14.2% | -1.8% | +12.5% | +5.9% | -5.1% | +6.3% | -22.0% | +23.0% | +82.9% | -83.2% | +378.9% | 0.0% | +48.4% | -82.0% | +256.4% | -8.3% | +5.3% | +7.0% | +0.8% | – | |
| – | -17.6% | +33.6% | +12.9% | -5.2% | +16.7% | +3.1% | +16.7% | +11.7% | -0.3% | +14.4% | +25.5% | +2.9% | +26.2% | +8.8% | -10.1% | -7.3% | +16.2% | +10.3% | +7.7% | +5.9% | +15.3% | -7.8% | +8.7% | +0.7% | +6.6% | +3.6% | -2.3% | +5.7% | +2.5% | -5.3% | -8.6% | +6.0% | +6.4% | +5.3% | -3.1% | +37.5% | +62.0% | -41.9% | -30.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | -49.9% | -35.1% | -65.3% | -11.7% | -38.0% | +60.0% | +12.5% | -21.5% | +263.2% | +101.8% | +121.0% | +103.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -218.0% | – | -221.0% | – | -461.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.